New Million-Dollar Trial for Multiple Sclerosis Drug

Cleveland Clinic has been selected as the primary investigator in a $11.3 million nationwide study funded primarily by the National Institutes of Health to conduct a trial of the oral drug ibudilast for progressive multiple sclerosis (MS) patients. The Phase 2 study will enroll patients at 28 clinical sites across the U.S. The trial is … Read More